Use code BLUE125 to save big on select memberships!

Many Middle-Aged Adults Wary of Taking Part in Studies of Dementia Prevention Drugs

November 2, 2022


Read time:

<5 mins

Drug companies and university-based teams are working urgently to find and test new medications that could prevent or slow the decline of brain function in older adults. Researchers from the University of Michigan School of Public Health noted from the National Poll on Healthy Aging, based at the University of Michigan Institute for Healthcare Policy and Innovation, that only about 5% of people polled would agree to test new dementia drugs. With Alzheimer’s and dementia impacting millions of Americans yearly, the study suggests they’ll need to work harder to find volunteers for their clinical trials.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.